206 related articles for article (PubMed ID: 31658067)
1. Affordability versus innovation: Is compulsory licensing the solution?
Pandey E; Paul SB
Int J Risk Saf Med; 2019; 30(4):233-247. PubMed ID: 31658067
[TBL] [Abstract][Full Text] [Related]
2. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
3. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
4. Compulsory Licensing of Pharmaceuticals in High-Income Countries: A Comparative Analysis.
Qunaj L; Kaltenboeck A; Bach PB
Milbank Q; 2022 Mar; 100(1):284-313. PubMed ID: 35257415
[TBL] [Abstract][Full Text] [Related]
5. Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
Danzon PM; Towse A
Int J Health Care Finance Econ; 2003 Sep; 3(3):183-205. PubMed ID: 14625999
[TBL] [Abstract][Full Text] [Related]
6. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.
Son KB; Lee TJ
Glob Public Health; 2018 Sep; 13(9):1169-1178. PubMed ID: 28585477
[TBL] [Abstract][Full Text] [Related]
7. Compulsory licensing of pharmaceuticals reconsidered: Current situation and implications for access to medicines.
Son KB; Lee TJ
Glob Public Health; 2018 Oct; 13(10):1430-1440. PubMed ID: 29183271
[TBL] [Abstract][Full Text] [Related]
8. Compulsory licensing often did not produce lower prices for antiretrovirals compared to international procurement.
Beall RF; Kuhn R; Attaran A
Health Aff (Millwood); 2015 Mar; 34(3):493-501. PubMed ID: 25732501
[TBL] [Abstract][Full Text] [Related]
9. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
10. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
11. Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
Ooms G; Forman L; Williams OD; Hill PS
BMC Int Health Hum Rights; 2014 Dec; 14():37. PubMed ID: 25518744
[TBL] [Abstract][Full Text] [Related]
12. Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?
Pandey E; Paul SB
Int J Risk Saf Med; 2019; 30(3):179-192. PubMed ID: 31450515
[TBL] [Abstract][Full Text] [Related]
13. The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access.
Esmail LC; Kohler JC
Global Health; 2012 Apr; 8():7. PubMed ID: 22472291
[TBL] [Abstract][Full Text] [Related]
14. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.
't Hoen EF; Veraldi J; Toebes B; Hogerzeil HV
Bull World Health Organ; 2018 Mar; 96(3):185-193. PubMed ID: 29531417
[TBL] [Abstract][Full Text] [Related]
15. Access to critical medicines: When are compulsory licenses effective in price negotiations?
Ramani SV; Urias E
Soc Sci Med; 2015 Jun; 135():75-83. PubMed ID: 25957163
[TBL] [Abstract][Full Text] [Related]
16. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
Crager SE; Guillen E; Price M
Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
[TBL] [Abstract][Full Text] [Related]
17. Compulsory patent licensing and local drug manufacturing capacity in Africa.
Owoeye OA
Bull World Health Organ; 2014 Mar; 92(3):214-9. PubMed ID: 24700981
[TBL] [Abstract][Full Text] [Related]
18. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
19. Learning from practice: compulsory licensing cases and access to medicines.
Stirner B
Pharm Pat Anal; 2012 Nov; 1(5):555-75. PubMed ID: 24236925
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
Guennif S
Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
